Literature DB >> 8306161

Morbidity following groin dissection for penile carcinoma.

R Ravi1.   

Abstract

From 1962 to 1990, 231 inguinal and 174 ilio-inguinal lymphadenectomies were performed on 234 patients with penile carcinoma. The morbidity of inguinal lymphadenectomy included wound infection in 18%, skin edge necrosis in 61%, seroma formation in 5% of dissections, and lymphoedema in 25% of limbs. The morbidity of ilio-inguinal lymphadenectomy included wound infection in 14%, skin edge necrosis in 64%, seroma formation in 9% of dissections, and lymphoedema in 29% of limbs. Pre-operative radiation to the groin significantly increased the healing complications. The routine use of a myocutaneous flap for primary reconstruction of the groin following ilio-inguinal lymphadenectomy resulted in 100% primary wound healing and significantly reduced the post-operative hospital stay to a mean of 10 days.

Entities:  

Mesh:

Year:  1993        PMID: 8306161     DOI: 10.1111/j.1464-410x.1993.tb16304.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  20 in total

1.  Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients.

Authors:  Sharon B Chang; Robert L Askew; Yan Xing; Storm Weaver; Jeffrey E Gershenwald; Jeffrey E Lee; Richard Royal; Anthony Lucci; Merrick I Ross; Janice N Cormier
Journal:  Ann Surg Oncol       Date:  2010-03-25       Impact factor: 5.344

Review 2.  Contemporary management of patients with penile cancer and lymph node metastasis.

Authors:  Andrew Leone; Gregory J Diorio; Curtis Pettaway; Viraj Master; Philippe E Spiess
Journal:  Nat Rev Urol       Date:  2017-04-11       Impact factor: 14.432

3.  [Surgical treatment of groin soft tissue defects].

Authors:  H Fansa; I C Warnecke; S Brüner; O Frerichs
Journal:  Chirurg       Date:  2006-05       Impact factor: 0.955

Review 4.  [Lymph node management of cN0 penile cancer].

Authors:  F Wawroschek; A Winter
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

5.  Minimizing Post-operative Complications of Groin Dissection Using Modified Skin Bridge Technique: A Single-Centre Descriptive Study Showing Post-operative and Early Oncological Outcomes.

Authors:  Mukur Dipi Ray; Ashish Jakhetiya; Sunil Kumar; Ashutosh Mishra; Seema Singh; Nootan Kumar Shukla
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

6.  Tensor fascia lata flap reconstruction following groin dissection: is it worthwhile?

Authors:  T J Nirmal; Ashish K Gupta; Santosh Kumar; Antony Devasia; Ninan Chacko; Nitin S Kekre
Journal:  World J Urol       Date:  2011-05-31       Impact factor: 4.226

7.  Inguinal Lymph Nodes in Carcinoma Penis-Observation or Surgery?

Authors:  Syed Althaf; Rajkumar P Narayanakar; Dinesh M Gangaiah; Kapil Dev; Vishnu P Kurpad; Jaiprakash Gurawalia
Journal:  J Clin Diagn Res       Date:  2016-01-01

Review 8.  Contemporary inguinal lymph node dissection: minimizing complications.

Authors:  Philippe E Spiess; Mike S Hernandez; Curtis A Pettaway
Journal:  World J Urol       Date:  2008-09-02       Impact factor: 4.226

9.  DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinoma.

Authors:  Oliver J Kayes; Marco Loddo; Nimish Patel; Pranav Patel; Suks Minhas; Gareth Ambler; Alex Freeman; Alex Wollenschlaeger; David J Ralph; Kai Stoeber; Gareth H Williams
Journal:  Clin Cancer Res       Date:  2009-11-17       Impact factor: 12.531

10.  Penile cancer: Clinical Practice Guidelines in Oncology.

Authors:  Peter E Clark; Philippe E Spiess; Neeraj Agarwal; Matthew C Biagioli; Mario A Eisenberger; Richard E Greenberg; Harry W Herr; Brant A Inman; Deborah A Kuban; Timothy M Kuzel; Subodh M Lele; Jeff Michalski; Lance Pagliaro; Sumanta K Pal; Anthony Patterson; Elizabeth R Plimack; Kamal S Pohar; Michael P Porter; Jerome P Richie; Wade J Sexton; William U Shipley; Eric J Small; Donald L Trump; Geoffrey Wile; Timothy G Wilson; Mary Dwyer; Maria Ho
Journal:  J Natl Compr Canc Netw       Date:  2013-05-01       Impact factor: 11.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.